Global Proteomics Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022
The proteomics market is segmented on the basis of proteomics instrumentation technology such as protein micro array (biochips, micro array instruments), spectroscopy (Mass and NMR), X-ray crystallography, chromatography, electrophoresis, proteomics reagents, proteomics services (analytical lab services, protein identification, extraction, sequencing, data analysis, maintaining bioinformatics data bases). The market is driven by growing need of personalized medicines, new discoveries in the field of genomics, rise in funds for proteomics based research, growing research and development expenditure, advancement in technologies, new techniques, high output, high resolutions achiness and instruments have been developed, availability of private funds and rise in the Asian markets like China and Japan. The top 10 companies own 40 to 50 percent of the market. Proteomic instrumentation market is dominated by proteomic microarray, accounting for around 50% of the revenue followed by spectroscopy techniques. Proteomic reagents market is dominated by immunoassays.
The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research and market is limited to a few developed nations only.
Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise. Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Major players in the proteomics market are Thermo Fischer scientific corporation, Agilent technologies, Luminex corporation, Sigma-Aldrich corporation, Danaher corporation, Bio-Rad corporation, Waters corporation, PerkinElmer, Affymetrix and others.
Companies profiled
1. Genzyme Corporation
2. Thermo Fischer scientific corporation
3. Becton Dickinson and Co
4. BG medicine
5. Agilent technologies
6. Luminex corporation
7. Sigma-Aldrich corporation
8. Danaher corporation
9. Anaspec Inc
10. Asterand PLC
11. Applied biosystems Inc
12. Bayer technology
13. Bio-Rad corporation
14. Waters corporation
15. PerkinElmer
16. Affymetrix
17. GE healthcare
18. Genesystems Inc
19. Activx Biosciences Inc
20. Amgen Inc
21. Beckman coulter
22. Biacore International AB
23. Biocarta Inc
24. Bruker biosciences
25. Caliper Lifesciences
26. Cellzome AG
27. Commonwealth biotechnologies
28. Digilab biovision GmBH
29. Dionex Corp
30. Dualsystems biotech AG
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. In-depth profiling of companies
The market is restrained by various factors such as: success ratio of the researches is not very high, limitations of personalized medicines and lengthy regulatory approval process, reduction in funds by the US government, which owes 40% of this market, highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research and market is limited to a few developed nations only.
Major opportunities for the market lie in the Asian markets where contract research organizations are on a rise. Proteomics is science with broad applications in the field of therapeutics and diagnostics. Growing R&D and emergence of new players will create more market opportunities. Major players in the proteomics market are Thermo Fischer scientific corporation, Agilent technologies, Luminex corporation, Sigma-Aldrich corporation, Danaher corporation, Bio-Rad corporation, Waters corporation, PerkinElmer, Affymetrix and others.
Companies profiled
1. Genzyme Corporation
2. Thermo Fischer scientific corporation
3. Becton Dickinson and Co
4. BG medicine
5. Agilent technologies
6. Luminex corporation
7. Sigma-Aldrich corporation
8. Danaher corporation
9. Anaspec Inc
10. Asterand PLC
11. Applied biosystems Inc
12. Bayer technology
13. Bio-Rad corporation
14. Waters corporation
15. PerkinElmer
16. Affymetrix
17. GE healthcare
18. Genesystems Inc
19. Activx Biosciences Inc
20. Amgen Inc
21. Beckman coulter
22. Biacore International AB
23. Biocarta Inc
24. Bruker biosciences
25. Caliper Lifesciences
26. Cellzome AG
27. Commonwealth biotechnologies
28. Digilab biovision GmBH
29. Dionex Corp
30. Dualsystems biotech AG
This Occams Research Report covers
1. Historical data
2. Revenue forecasts, growth rates and CAGR upto 2022
3. Industry Analysis
4. Competitive Analysis
5. Key geographic growth data
6. In-depth profiling of companies
1. INTRODUCTION
1.1. Executive summary
1.2. Estimation methodology
2. MARKET OVERVIEW
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Global proteomic R&D expenditure
2.3.2. Global personalized medicine market
2.3.3. Global drug discovery programs
2.3.4. Healthcare expenditure across geographies
2.3.5. Disposable income of top emerging economies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. R&D scenario in proteomics market
2.4.5. Pricing analysis
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: Top competitive moves
2.6. Value Chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions
3. MARKET DETERMINANTS
3.1. Market drivers
3.1.1. Increased funding by government and private firms in research and development
3.1.2. Increased demand for personalized medicine
3.1.3. High elderly population and prevalence of lifestyle diseases
3.1.4. Technology advancements
3.1.5. Increased understanding of human genome
3.2. Market Restraints
3.2.1. The success ratio of the researches is not very high
3.2.2. Number of non responders is very high
3.2.3. Reduction in funds by the US government, which owes 40% of this market
3.2.4. Highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research
3.2.5. Market is limited to a few developed nations only.
3.3. Market challenges
3.3.1. High price
3.3.2. Weak research and development in emerging markets
3.4. Market opportunities
3.4.1. Development in drug discovery and nanotechnolgy
3.4.2. Markets in emerging geographies
4. SECTOR ANALYSIS
4.1. Parent market
4.2. Sub-segment market
4.3. Alternative market
5. MARKET SEGMENTATION
5.1. Global proteomics market, by technology, 2014-2021, ($millions)
5.1.1. Global protein microarray in proteomics market, 2014-2021, ($millions)
5.1.1.1. Global biochips in proteomics market, 2014-2021, ($millions)
5.1.1.2. Global microarray instruments proteomics market, 2014-2021, ($millions)
5.1.1.3. Global spectroscopy in proteomics market, 2014-2021, ($millions)
5.1.1.4. Global X-ray crystallography in proteomics market, 2014-2021, ($millions)
5.1.1.5. Global chromatography in proteomics market, 2014-2021, ($millions)
5.1.1.6. Global chromatography in proteomics market, 2014-2021, ($millions)
5.1.1.7. Global surface plasmon resonance in proteomics market, 2014-2021, ($millions)
5.1.1.8. Global protein fractionation in proteomics market, 2014-2021, ($millions)
5.1.2. Global proteomics reagents market, 2014-2021, ($millions)
5.1.2.1. Global microarray reagents market, 2014-2021, ($millions)
5.1.2.2. Global X-ray crystallography reagents market, 2014-2021, ($millions)
5.1.2.3. Global spectroscopy reagents market, 2014-2021, ($millions)
5.1.2.4. Global immunoassay reagents market, 2014-2021, ($millions)
5.1.2.5. Global chromatography reagents market, 2014-2021, ($millions)
5.1.2.6. Global electrophoresis reagents market, 2014-2021, ($millions)
5.1.2.7. Global protein fractionation reagents market, 2014-2021, ($millions)
5.2. Global proteomics services market, 2014-2021
5.2.1. Global analytical lab services market, 2014-2021, ($millions)
5.2.1.1. Global protein identification market, 2014-2021, ($millions)
5.2.1.2. Global protein extraction market, 2014-2021, ($millions)
5.2.1.3. Global protein sequencing market, 2014-2021, ($millions)
5.2.2. Global data analysis and maintenance market, 2014-2021, ($millions)
5.2.2.1. Global bioinformatics database market, 2014-2021, ($millions)
5.2.2.2. Global bioinformatics tools market, 2014-2021, ($millions)
5.3. Global proteomics market by applications, 2014-2021, ($millions)
5.3.1. Global proteomics in drug discovery market, 2014-2021, ($millions)
5.3.1.1. Neuro-medicine
5.3.1.2. Maternal
5.3.1.3. Cancer
5.3.1.4. Antibody
5.3.1.5. Cardiovascular
5.3.1.6. Diabetes
5.3.1.7. Nutrition
5.3.1.8. Others
5.3.2. Global proteomics in clinical diagnosis market, 2014-2021, ($millions)
6. COMPETITIVE LANDSCAPE
6.1. Market share
6.2. Strategy – An analysis across tiers
7. GEOGRAPHICAL ANALYSIS
7.1. North America Proteomic market, 2014-2021, ($millions)
7.2. United States (U.S.) Proteomic market, 2014-2021, ($millions)
7.3. Canada Proteomic market, 2014-2021, ($millions)
7.4. Europe Proteomic market, 2014-2021, ($millions)
7.4.1. United Kingdom (UK) Proteomic market, 2014-2021, ($millions)
7.4.2. France Proteomic market, 2014-2021, ($millions)
7.4.3. Germany Proteomic market, 2014-2021, ($millions)
7.4.4. Spain Proteomic market, 2014-2021, ($millions)
7.4.5. Italy Proteomic market, 2014-2021, ($millions)
7.4.6. RoE Proteomic market, 2014-2021, ($millions)
7.5. Asia Pacific Proteomic market, 2014-2021, ($millions)
7.5.1. India Proteomic market, 2014-2021, ($millions)
7.5.2. China Proteomic market, 2014-2021, ($millions)
7.5.3. Japan Proteomic market, 2014-2021, ($millions)
7.5.4. Korea Proteomic market, 2014-2021, ($millions)
7.5.5. Australia Proteomic market, 2014-2021, ($millions)
7.5.6. RoAPAC Proteomic market, 2014-2021, ($millions)
7.6. Rest of the world Proteomic market, 2014-2021, ($millions)
7.6.1. Latin America Proteomic market, 2014-2021, ($millions)
7.6.2. MENA Proteomic market, 2014-2021, ($millions)
7.6.3. Africa Proteomic market, 2014-2021, ($millions)
8. COMPANY PROFILES:
8.1. Genzyme Corporation
8.2. Thermo Fischer scientific corporation
8.3. Becton Dickinson and Co.
8.4. BG medicine
8.5. Agilent technologies
8.6. Luminex corporation
8.7. Sigma-Aldrich corporation
8.8. Danaher corporation
8.9. Anaspec Inc
8.10. Asterand PLC
8.11. Applied biosystems Inc.
8.12. Bayer technology
8.13. Bio-Rad corporation
8.14. Waters corporation
8.15. PerkinElmer
8.16. Affymetrix
8.17. GE healthcare
8.18. Genesystems Inc.
8.19. Activx Biosciences Inc.
8.20. Amgen Inc
8.21. Beckman coulter
8.22. Biacore International AB
8.23. Biocarta Inc
8.24. Bruker biosciences
8.25. Caliper Lifesciences
8.26. Cellzome AG
8.27. Commonwealth biotechnologies
8.28. Digilab biovision GmBH
8.29. Dionex Corp.
8.30. Dualsystems biotech AG
1.1. Executive summary
1.2. Estimation methodology
2. MARKET OVERVIEW
2.1. Market definition and scope
2.2. Key findings
2.3. Parametric analysis
2.3.1. Global proteomic R&D expenditure
2.3.2. Global personalized medicine market
2.3.3. Global drug discovery programs
2.3.4. Healthcare expenditure across geographies
2.3.5. Disposable income of top emerging economies
2.4. Key market insights
2.4.1. Top 3 emerging countries
2.4.2. Top 3 revenue generating segments
2.4.3. Top growing markets and emerging trends
2.4.4. R&D scenario in proteomics market
2.4.5. Pricing analysis
2.5. Competitive intelligence
2.5.1. Market share analysis
2.5.2. Top winning strategies
2.5.3. Case studies: Top competitive moves
2.6. Value Chain analysis
2.7. Key buying criteria
2.8. Strategic recommendation
2.9. Strategic conclusions
3. MARKET DETERMINANTS
3.1. Market drivers
3.1.1. Increased funding by government and private firms in research and development
3.1.2. Increased demand for personalized medicine
3.1.3. High elderly population and prevalence of lifestyle diseases
3.1.4. Technology advancements
3.1.5. Increased understanding of human genome
3.2. Market Restraints
3.2.1. The success ratio of the researches is not very high
3.2.2. Number of non responders is very high
3.2.3. Reduction in funds by the US government, which owes 40% of this market
3.2.4. Highly expensive medicines, which are 1000 fold costlier than the normal medicines present in the market and research
3.2.5. Market is limited to a few developed nations only.
3.3. Market challenges
3.3.1. High price
3.3.2. Weak research and development in emerging markets
3.4. Market opportunities
3.4.1. Development in drug discovery and nanotechnolgy
3.4.2. Markets in emerging geographies
4. SECTOR ANALYSIS
4.1. Parent market
4.2. Sub-segment market
4.3. Alternative market
5. MARKET SEGMENTATION
5.1. Global proteomics market, by technology, 2014-2021, ($millions)
5.1.1. Global protein microarray in proteomics market, 2014-2021, ($millions)
5.1.1.1. Global biochips in proteomics market, 2014-2021, ($millions)
5.1.1.2. Global microarray instruments proteomics market, 2014-2021, ($millions)
5.1.1.3. Global spectroscopy in proteomics market, 2014-2021, ($millions)
5.1.1.4. Global X-ray crystallography in proteomics market, 2014-2021, ($millions)
5.1.1.5. Global chromatography in proteomics market, 2014-2021, ($millions)
5.1.1.6. Global chromatography in proteomics market, 2014-2021, ($millions)
5.1.1.7. Global surface plasmon resonance in proteomics market, 2014-2021, ($millions)
5.1.1.8. Global protein fractionation in proteomics market, 2014-2021, ($millions)
5.1.2. Global proteomics reagents market, 2014-2021, ($millions)
5.1.2.1. Global microarray reagents market, 2014-2021, ($millions)
5.1.2.2. Global X-ray crystallography reagents market, 2014-2021, ($millions)
5.1.2.3. Global spectroscopy reagents market, 2014-2021, ($millions)
5.1.2.4. Global immunoassay reagents market, 2014-2021, ($millions)
5.1.2.5. Global chromatography reagents market, 2014-2021, ($millions)
5.1.2.6. Global electrophoresis reagents market, 2014-2021, ($millions)
5.1.2.7. Global protein fractionation reagents market, 2014-2021, ($millions)
5.2. Global proteomics services market, 2014-2021
5.2.1. Global analytical lab services market, 2014-2021, ($millions)
5.2.1.1. Global protein identification market, 2014-2021, ($millions)
5.2.1.2. Global protein extraction market, 2014-2021, ($millions)
5.2.1.3. Global protein sequencing market, 2014-2021, ($millions)
5.2.2. Global data analysis and maintenance market, 2014-2021, ($millions)
5.2.2.1. Global bioinformatics database market, 2014-2021, ($millions)
5.2.2.2. Global bioinformatics tools market, 2014-2021, ($millions)
5.3. Global proteomics market by applications, 2014-2021, ($millions)
5.3.1. Global proteomics in drug discovery market, 2014-2021, ($millions)
5.3.1.1. Neuro-medicine
5.3.1.2. Maternal
5.3.1.3. Cancer
5.3.1.4. Antibody
5.3.1.5. Cardiovascular
5.3.1.6. Diabetes
5.3.1.7. Nutrition
5.3.1.8. Others
5.3.2. Global proteomics in clinical diagnosis market, 2014-2021, ($millions)
6. COMPETITIVE LANDSCAPE
6.1. Market share
6.2. Strategy – An analysis across tiers
7. GEOGRAPHICAL ANALYSIS
7.1. North America Proteomic market, 2014-2021, ($millions)
7.2. United States (U.S.) Proteomic market, 2014-2021, ($millions)
7.3. Canada Proteomic market, 2014-2021, ($millions)
7.4. Europe Proteomic market, 2014-2021, ($millions)
7.4.1. United Kingdom (UK) Proteomic market, 2014-2021, ($millions)
7.4.2. France Proteomic market, 2014-2021, ($millions)
7.4.3. Germany Proteomic market, 2014-2021, ($millions)
7.4.4. Spain Proteomic market, 2014-2021, ($millions)
7.4.5. Italy Proteomic market, 2014-2021, ($millions)
7.4.6. RoE Proteomic market, 2014-2021, ($millions)
7.5. Asia Pacific Proteomic market, 2014-2021, ($millions)
7.5.1. India Proteomic market, 2014-2021, ($millions)
7.5.2. China Proteomic market, 2014-2021, ($millions)
7.5.3. Japan Proteomic market, 2014-2021, ($millions)
7.5.4. Korea Proteomic market, 2014-2021, ($millions)
7.5.5. Australia Proteomic market, 2014-2021, ($millions)
7.5.6. RoAPAC Proteomic market, 2014-2021, ($millions)
7.6. Rest of the world Proteomic market, 2014-2021, ($millions)
7.6.1. Latin America Proteomic market, 2014-2021, ($millions)
7.6.2. MENA Proteomic market, 2014-2021, ($millions)
7.6.3. Africa Proteomic market, 2014-2021, ($millions)
8. COMPANY PROFILES:
8.1. Genzyme Corporation
8.2. Thermo Fischer scientific corporation
8.3. Becton Dickinson and Co.
8.4. BG medicine
8.5. Agilent technologies
8.6. Luminex corporation
8.7. Sigma-Aldrich corporation
8.8. Danaher corporation
8.9. Anaspec Inc
8.10. Asterand PLC
8.11. Applied biosystems Inc.
8.12. Bayer technology
8.13. Bio-Rad corporation
8.14. Waters corporation
8.15. PerkinElmer
8.16. Affymetrix
8.17. GE healthcare
8.18. Genesystems Inc.
8.19. Activx Biosciences Inc.
8.20. Amgen Inc
8.21. Beckman coulter
8.22. Biacore International AB
8.23. Biocarta Inc
8.24. Bruker biosciences
8.25. Caliper Lifesciences
8.26. Cellzome AG
8.27. Commonwealth biotechnologies
8.28. Digilab biovision GmBH
8.29. Dionex Corp.
8.30. Dualsystems biotech AG
LIST OF TABLES
GLOBAL PROTEOMICS MARKET, BY TECHNOLOGY 2014-2022 ($ MILLION)
10. GLOBAL PROTEIN MICROARRAY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
11. GLOBAL BIOCHIPS IN PROTEOMICS MARKET, 2014-2021, ($MILLIONS)
12. GLOBAL MICROARRAY INSTRUMENTS PROTEOMICS MARKET 2014-2022 ($ MILLION)
13. GLOBAL SPECTROSCOPY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
14. GLOBAL X-RAY CRYSTALLOGRAPHY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
15. GLOBAL CHROMATOGRAPHY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
16. GLOBAL CHROMATOGRAPHY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
17. GLOBAL SURFACE PLASMON RESONANCE IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
18. GLOBAL PROTEIN FRACTIONATION IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
19. GLOBAL PROTEOMICS REAGENTS MARKET 2014-2022 ($ MILLION)
20. GLOBAL MICROARRAY REAGENTS MARKET 2014-2022 ($ MILLION)
21. GLOBAL X-RAY CRYSTALLOGRAPHY REAGENTS MARKET 2014-2022 ($ MILLION)
22. GLOBAL SPECTROSCOPY REAGENTS MARKET 2014-2022 ($ MILLION)
23. GLOBAL IMMUNOASSAY REAGENTS MARKET 2014-2022 ($ MILLION)
24. GLOBAL CHROMATOGRAPHY REAGENTS MARKET 2014-2022 ($ MILLION)
25. GLOBAL ELECTROPHORESIS REAGENTS MARKET 2014-2022 ($ MILLION)
26. GLOBAL PROTEIN FRACTIONATION REAGENTS MARKET 2014-2022 ($ MILLION)
27. GLOBAL PROTEOMICS SERVICES MARKET, 2014-2021
28. GLOBAL ANALYTICAL LAB SERVICES MARKET 2014-2022 ($ MILLION)
29. GLOBAL PROTEIN IDENTIFICATION MARKET 2014-2022 ($ MILLION)
30. GLOBAL PROTEIN EXTRACTION MARKET 2014-2022 ($ MILLION)
31. GLOBAL PROTEIN SEQUENCING MARKET 2014-2022 ($ MILLION)
32. GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET 2014-2022 ($ MILLION)
33. GLOBAL BIOINFORMATICS DATABASE MARKET 2014-2022 ($ MILLION)
34. GLOBAL BIOINFORMATICS TOOLS MARKET 2014-2022 ($ MILLION)
35. GLOBAL PROTEOMICS MARKET BY APPLICATIONS 2014-2022 ($ MILLION)
36. GLOBAL PROTEOMICS IN DRUG DISCOVERY MARKET 2014-2022 ($ MILLION)
37. NEURO-MEDICINE DRUG DISCOVERY MARKET 2014-2022 ($ MILLION)
38. MATERNAL DRUG DISCOVERY MARKET 2014-2022 ($ MILLION)
39. CANCER MARKET 2014-2022 ($ MILLION)
40. ANTIBODY MARKET 2014-2022 ($ MILLION)
41. CARDIOVASCULAR MARKET 2014-2022 ($ MILLION)
42. DIABETES MARKET 2014-2022 ($ MILLION)
43. OTHERS MARKET 2014-2022 ($ MILLION)
44. GLOBAL PROTEOMICS IN CLINICAL DIAGNOSIS MARKET 2014-2022 ($ MILLION)
GLOBAL PROTEOMICS MARKET, BY TECHNOLOGY 2014-2022 ($ MILLION)
10. GLOBAL PROTEIN MICROARRAY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
11. GLOBAL BIOCHIPS IN PROTEOMICS MARKET, 2014-2021, ($MILLIONS)
12. GLOBAL MICROARRAY INSTRUMENTS PROTEOMICS MARKET 2014-2022 ($ MILLION)
13. GLOBAL SPECTROSCOPY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
14. GLOBAL X-RAY CRYSTALLOGRAPHY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
15. GLOBAL CHROMATOGRAPHY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
16. GLOBAL CHROMATOGRAPHY IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
17. GLOBAL SURFACE PLASMON RESONANCE IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
18. GLOBAL PROTEIN FRACTIONATION IN PROTEOMICS MARKET 2014-2022 ($ MILLION)
19. GLOBAL PROTEOMICS REAGENTS MARKET 2014-2022 ($ MILLION)
20. GLOBAL MICROARRAY REAGENTS MARKET 2014-2022 ($ MILLION)
21. GLOBAL X-RAY CRYSTALLOGRAPHY REAGENTS MARKET 2014-2022 ($ MILLION)
22. GLOBAL SPECTROSCOPY REAGENTS MARKET 2014-2022 ($ MILLION)
23. GLOBAL IMMUNOASSAY REAGENTS MARKET 2014-2022 ($ MILLION)
24. GLOBAL CHROMATOGRAPHY REAGENTS MARKET 2014-2022 ($ MILLION)
25. GLOBAL ELECTROPHORESIS REAGENTS MARKET 2014-2022 ($ MILLION)
26. GLOBAL PROTEIN FRACTIONATION REAGENTS MARKET 2014-2022 ($ MILLION)
27. GLOBAL PROTEOMICS SERVICES MARKET, 2014-2021
28. GLOBAL ANALYTICAL LAB SERVICES MARKET 2014-2022 ($ MILLION)
29. GLOBAL PROTEIN IDENTIFICATION MARKET 2014-2022 ($ MILLION)
30. GLOBAL PROTEIN EXTRACTION MARKET 2014-2022 ($ MILLION)
31. GLOBAL PROTEIN SEQUENCING MARKET 2014-2022 ($ MILLION)
32. GLOBAL DATA ANALYSIS AND MAINTENANCE MARKET 2014-2022 ($ MILLION)
33. GLOBAL BIOINFORMATICS DATABASE MARKET 2014-2022 ($ MILLION)
34. GLOBAL BIOINFORMATICS TOOLS MARKET 2014-2022 ($ MILLION)
35. GLOBAL PROTEOMICS MARKET BY APPLICATIONS 2014-2022 ($ MILLION)
36. GLOBAL PROTEOMICS IN DRUG DISCOVERY MARKET 2014-2022 ($ MILLION)
37. NEURO-MEDICINE DRUG DISCOVERY MARKET 2014-2022 ($ MILLION)
38. MATERNAL DRUG DISCOVERY MARKET 2014-2022 ($ MILLION)
39. CANCER MARKET 2014-2022 ($ MILLION)
40. ANTIBODY MARKET 2014-2022 ($ MILLION)
41. CARDIOVASCULAR MARKET 2014-2022 ($ MILLION)
42. DIABETES MARKET 2014-2022 ($ MILLION)
43. OTHERS MARKET 2014-2022 ($ MILLION)
44. GLOBAL PROTEOMICS IN CLINICAL DIAGNOSIS MARKET 2014-2022 ($ MILLION)
LIST OF FIGURES
1. UNITED STATES (U.S.) PROTEOMIC MARKET 2014-2022 ($ MILLION)
2. CANADA PROTEOMIC MARKET 2014-2022 ($ MILLION)
3. UNITED KINGDOM (UK) PROTEOMIC MARKET 2014-2022 ($ MILLION)
4. FRANCE PROTEOMIC MARKET 2014-2022 ($ MILLION)
5. GERMANY PROTEOMIC MARKET 2014-2022 ($ MILLION)
6. SPAIN PROTEOMIC MARKET 2014-2022 ($ MILLION)
7. ITALY PROTEOMIC MARKET 2014-2022 ($ MILLION)
8. ROE PROTEOMIC MARKET 2014-2022 ($ MILLION)
9. INDIA PROTEOMIC MARKET 2014-2022 ($ MILLION)
10. CHINA PROTEOMIC MARKET 2014-2022 ($ MILLION)
11. JAPAN PROTEOMIC MARKET 2014-2022 ($ MILLION)
12. KOREA PROTEOMIC MARKET 2014-2022 ($ MILLION)
13. AUSTRALIA PROTEOMIC MARKET 2014-2022 ($ MILLION)
14. ROAPAC PROTEOMIC MARKET 2014-2022 ($ MILLION)
COMPANIES MENTIONED
1. Genzyme Corporation
2. Thermo Fischer scientific corporation
3. Becton Dickinson and Co
4. BG medicine
5. Agilent technologies
6. Luminex corporation
7. Sigma-Aldrich corporation
8. Danaher corporation
9. Anaspec Inc
10. Asterand PLC
11. Applied biosystems Inc
12. Bayer technology
13. Bio-Rad corporation
14. Waters corporation
15. PerkinElmer
16. Affymetrix
17. GE healthcare
18. Genesystems Inc
19. Activx Biosciences Inc
20. Amgen Inc
21. Beckman coulter
22. Biacore International AB
23. Biocarta Inc
24. Bruker biosciences
25. Caliper Lifesciences
26. Cellzome AG
27. Commonwealth biotechnologies
28. Digilab biovision GmBH
29. Dionex Corp
30. Dualsystems biotech AG
1. UNITED STATES (U.S.) PROTEOMIC MARKET 2014-2022 ($ MILLION)
2. CANADA PROTEOMIC MARKET 2014-2022 ($ MILLION)
3. UNITED KINGDOM (UK) PROTEOMIC MARKET 2014-2022 ($ MILLION)
4. FRANCE PROTEOMIC MARKET 2014-2022 ($ MILLION)
5. GERMANY PROTEOMIC MARKET 2014-2022 ($ MILLION)
6. SPAIN PROTEOMIC MARKET 2014-2022 ($ MILLION)
7. ITALY PROTEOMIC MARKET 2014-2022 ($ MILLION)
8. ROE PROTEOMIC MARKET 2014-2022 ($ MILLION)
9. INDIA PROTEOMIC MARKET 2014-2022 ($ MILLION)
10. CHINA PROTEOMIC MARKET 2014-2022 ($ MILLION)
11. JAPAN PROTEOMIC MARKET 2014-2022 ($ MILLION)
12. KOREA PROTEOMIC MARKET 2014-2022 ($ MILLION)
13. AUSTRALIA PROTEOMIC MARKET 2014-2022 ($ MILLION)
14. ROAPAC PROTEOMIC MARKET 2014-2022 ($ MILLION)
COMPANIES MENTIONED
1. Genzyme Corporation
2. Thermo Fischer scientific corporation
3. Becton Dickinson and Co
4. BG medicine
5. Agilent technologies
6. Luminex corporation
7. Sigma-Aldrich corporation
8. Danaher corporation
9. Anaspec Inc
10. Asterand PLC
11. Applied biosystems Inc
12. Bayer technology
13. Bio-Rad corporation
14. Waters corporation
15. PerkinElmer
16. Affymetrix
17. GE healthcare
18. Genesystems Inc
19. Activx Biosciences Inc
20. Amgen Inc
21. Beckman coulter
22. Biacore International AB
23. Biocarta Inc
24. Bruker biosciences
25. Caliper Lifesciences
26. Cellzome AG
27. Commonwealth biotechnologies
28. Digilab biovision GmBH
29. Dionex Corp
30. Dualsystems biotech AG
